Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 3
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02023034Not ApplicableCompleted

Virtual Exercises in Patients With Parkinson's Disease.

Role: lead

NCT01372020Phase 4Completed

Neuromuscular Electrical Therapy in Venous Ulcers

Role: lead

NCT01056081Phase 3Completed

Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease

Role: lead

NCT00935181Phase 4Completed

Respiratory Muscle Stretching in Chronic Obstructive Pulmonary Disease (COPD)

Role: lead

All 4 trials loaded